Public-registry trials using lerodalcibep that Eichor's radar has found — 3 trials. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product | LIB Therapeutics LLC | Hypercholesterolemia | PHASE3 | 1 |
| Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH | LIB Therapeutics LLC | Homozygous Familial Hypercholesterolemia | PHASE3 | 12 |
| Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction | LIB Therapeutics LLC | Heterozygous Familial Hypercholesterolemia | PHASE3 | 7 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
